Daré Bioscience, Inc.
DARE
$2.42
$0.020.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.33M | 15.70M | 11.23M | 16.42M | 3.63M |
| Total Receivables | 105.20K | 230.00K | 518.90K | 902.20K | 1.39M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.39M | 2.52M | 3.19M | 3.51M | 4.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 152.20K |
| Total Current Assets | 11.82M | 18.45M | 14.95M | 20.83M | 9.98M |
|
|
|||||
| Total Current Assets | 11.82M | 18.45M | 14.95M | 20.83M | 9.98M |
| Net Property, Plant & Equipment | 5.72M | 2.54M | 2.03M | 1.77M | 1.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.08M | 1.11M | 1.08M | 1.01M | 1.42M |
| Total Assets | 18.62M | 22.10M | 18.06M | 23.61M | 13.01M |
|
|
|||||
| Total Accounts Payable | 1.88M | 1.46M | 1.05M | 1.91M | 4.04M |
| Total Accrued Expenses | 1.77M | 3.04M | 1.85M | 1.25M | 1.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.32M | 548.60K | 505.80K | 488.20K | 470.40K |
| Total Finance Division Other Current Liabilities | 15.21M | 16.56M | 9.75M | 10.94M | 11.84M |
| Total Other Current Liabilities | 15.21M | 16.56M | 9.75M | 10.94M | 11.84M |
| Total Current Liabilities | 21.19M | 21.61M | 13.16M | 14.59M | 17.72M |
|
|
|||||
| Total Current Liabilities | 21.19M | 21.61M | 13.16M | 14.59M | 17.72M |
| Long-Term Debt | -- | -- | 4.49M | 4.31M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.25M | 754.40K | 897.80K | 1.04M | 1.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.74M | 5.75M | 1.00M | 1.00M | 5.12M |
| Total Liabilities | 28.18M | 28.11M | 19.54M | 20.93M | 24.01M |
|
|
|||||
| Common Stock & APIC | 170.52M | 169.71M | 168.66M | 168.14M | 167.39M |
| Retained Earnings | -179.67M | -175.29M | -169.78M | -165.08M | -177.99M |
| Treasury Stock & Other | -415.70K | -428.80K | -362.60K | -385.60K | -400.10K |
| Total Common Equity | -9.56M | -6.01M | -1.48M | 2.67M | -11.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.56M | -6.01M | -1.48M | 2.67M | -11.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.56M | -6.01M | -1.48M | 2.67M | -11.00M |
|
|
|||||